Symposia: Scientific Workshop on Challenges and Novel Technologies in Red Blood Cell Quality Assessment
Program: Scientific Workshops
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Artificial intelligence (AI), Translational Research, Assays, Bioinformatics, Blood banking, Emerging technologies, Technology and Procedures, Gene editing, Profiling, Imaging, Machine learning, Omics technologies
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Artificial intelligence (AI), Translational Research, Assays, Bioinformatics, Blood banking, Emerging technologies, Technology and Procedures, Gene editing, Profiling, Imaging, Machine learning, Omics technologies
Friday, December 6, 2024: 2:10 PM-3:25 PM
Room 3
(San Diego Convention Center)
Moderator:
and
Umut Gurkan, PhD, Case Western Reserve University
Disclosures:
Gurkan: Hemex Health Inc: Consultancy, Current Employment, Current equity holder in private company, Current holder of stock options in a privately-held company, Patents & Royalties, Research Funding; BioChip Labs Inc: Consultancy, Current Employment, Current equity holder in private company, Current holder of stock options in a privately-held company, Patents & Royalties, Research Funding; XaTek Inc: Patents & Royalties; DxNow Inc: Patents & Royalties.
In this session, we will bring together a diverse group of experts to discuss the challenges associated with red blood cell quality testing, including, blood bank, clinical, ethical, and societal perspectives.
denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.